Legal & General Group
BPTH

Legal & General Group’s Bio-Path Holdings Inc BPTH Stock Holding History

Legal & General Group’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-443
Closed -$681K – 3330
2017
Q2 		$681K Buy
443
+435
+5,438% +$912K ﹤0.01% 1966
2017
Q1 		$26K Hold
8
– – ﹤0.01% 3019
2016
Q4 		$43K Buy
8
+4
+100% +$19.4K ﹤0.01% 2924
2016
Q3 		$20K Hold
4
– – ﹤0.01% 2816
2016
Q2 		$29K Buy
+4
New +$40.5K ﹤0.01% 2756

Other funds holding BPTH

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCA
Rowland Carmichael Advisors Scottsdale, Arizona $316M AUM 18.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Legal & General Group's BPTH Position: Q3 2017 in Review

Legal & General Group sold out of Bio-Path Holdings Inc (BPTH) in Q3 2017, closing a stake of 443 shares — an estimated $681K sold.

Legal & General Group first reported a position in BPTH in Q2 2016 and held it in 5 quarters. The position peaked at $681K in Q2 2017. 26 funds tracked by Wall St. Rank hold BPTH as of Q3 2017.

  • Legal & General Group reported no remaining Bio-Path Holdings Inc position as of Q3 2017 after selling out during the quarter.
  • Legal & General Group sold 443 Bio-Path Holdings Inc shares in Q3 2017, an estimated $681K.
  • Legal & General Group first reported a position in Bio-Path Holdings Inc in Q2 2016 and held it in 5 quarters.
  • Legal & General Group's Bio-Path Holdings Inc position peaked at $681K in Q2 2017.
  • 26 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q3 2017.

Based on Legal & General Group's 13F filing for Q3 2017, filed 9 Nov 2017.